Russia to mass produce experimental Covid-19 vaccine - wealth fund head | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
The Business Standard

Thursday
November 30, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
THURSDAY, NOVEMBER 30, 2023
Russia to mass produce experimental Covid-19 vaccine - wealth fund head

Coronavirus chronicle

Reuters
16 July, 2020, 03:45 pm
Last modified: 16 July, 2020, 03:48 pm

Related News

  • Ukraine has a new way to get its grain to the world despite Russia's threat in the Black Sea
  • Currency clashes sour Russia's oil trade with Asia
  • Five wounded in Kyiv by largest ever drone attack on Ukraine
  • Zelensky says impossible to forgive 'genocide' of Stalin-era famine
  • BNP says Russian foreign ministry comments hurt sentiments of democracy-seeking people

Russia to mass produce experimental Covid-19 vaccine - wealth fund head

A larger Phase III trial involving several thousand people is expected to begin in August, said Russian Direct Investment Fund (RDIF) head Kirill Dmitriev

Reuters
16 July, 2020, 03:45 pm
Last modified: 16 July, 2020, 03:48 pm
A vial with potential vaccine for the coronavirus disease (Covid-19) is pictured at the Imperial College London, London, Britain June 10, 2020, Picture taken June 10, 2020. Imperial College London/Thomas Angus/via Reuters THIS IMAGE HAS BEEN SUPPLIED BY A THIRD PARTY. MANDATORY CREDIT. NO RESALES. NO ARCHIVES
A vial with potential vaccine for the coronavirus disease (Covid-19) is pictured at the Imperial College London, London, Britain June 10, 2020, Picture taken June 10, 2020. Imperial College London/Thomas Angus/via Reuters THIS IMAGE HAS BEEN SUPPLIED BY A THIRD PARTY. MANDATORY CREDIT. NO RESALES. NO ARCHIVES

Russia plans to produce 30 million doses of an experimental Covid-19 vaccine domestically this year, with the potential to manufacture a further 170 million abroad, the head of the country's sovereign wealth fund told Reuters.

The first human trial of the vaccine, a month-long test on 38 people, ended this week. Researchers concluded that it is safe for use and induces an immune response, though the strength of that response is as yet unclear.

A larger Phase III trial involving several thousand people is expected to begin in August, said Russian Direct Investment Fund (RDIF) head Kirill Dmitriev.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

"We believe that based on the current results it will be approved in Russia in August and in some other countries in September..., making it possibly the first vaccine to be approved in the world," he said in an interview.

More than 100 possible vaccines are being developed to try to stop the pandemic. At least two are in final Phase III human trials, according to World Health Organization data - one being developed by China's Sinopharm and the other by AstraZeneca and the University of Oxford.

Producers are also grappling with the question of how to massively scale up production to meet global needs.

HERD IMMUNITY

Dmitriev said the Russian Phase III trial will be conducted at home and in two Middle Eastern countries, and will begin after a 100-person Phase II trial wraps up on Aug. 3.

Russia was in talks with Saudi Arabia on being a trial site as well as a manufacturing partner, he told a separate news conference.

Moscow's Gamaleya Institute, which developed the Russian candidate vaccine, is producing doses for clinical trials, while private pharmaceutical firms Alium - part of the Sistema conglomerate- R-Pharm and are handling bottling.

Both are updating their lab setup to be able to take over production within the next couple of months, Dmitriev said.

"There's a general sense that for so-called herd immunity in Russia you need to vaccinate between 40 million and 50 million people," he told Reuters.

"So we believe we will be in good shape producing around 30 million (doses domestically) this year and then we can finalise vaccination next year."

Russia had also struck manufacturing deals with five other countries and could be producing up to 170 million doses abroad this year, Dmitriev said.

He declined to say where or give any details on pricing, but said countries in Latin America, the Middle East and elsewhere had expressed interest in importing the vaccine.

Russia has also reached a deal with drugmaker AstraZeneca on its potential Covid-19 vaccine, called AZD1222. "We expect one of our portfolio companies to also be working ...on producing the AstraZeneca vaccine in Russia," Dmitriev said.

Russia / Coronavirus Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Go for reforms as Five-Year Plan goes off track: Report
    Go for reforms as Five-Year Plan goes off track: Report
  • Small parties make big buzz. Polls look 'participatory'
    Small parties make big buzz. Polls look 'participatory'
  • File Photo: Reuters
    Dollar rate cut again, by Tk0.25, within a week

MOST VIEWED

  • Tax return time extension likely
    Tax return time extension likely
  • 12 expressways outlined for wider connectivity by 2041
    12 expressways outlined for wider connectivity by 2041
  • Photo: TBS
    Ctg city enters ‘Smart School Bus’ era
  • The architectural design of Anukrom is a triumph of purpose and ingenuity – a rectangular structure that stretches east to west, crafting out two courtyards. Photo: Shakil Hai
    Anukrom: A mother’s dream, a son’s guilt and an award-winning home
  • Representational image. 
Photo: Dmytro Demidko on Unsplash
    Usable forex reserves stands at $15.82 billion
  • File Photo: Reuters
    Reserves now at $19.52 billion: Bangladesh Bank

Related News

  • Ukraine has a new way to get its grain to the world despite Russia's threat in the Black Sea
  • Currency clashes sour Russia's oil trade with Asia
  • Five wounded in Kyiv by largest ever drone attack on Ukraine
  • Zelensky says impossible to forgive 'genocide' of Stalin-era famine
  • BNP says Russian foreign ministry comments hurt sentiments of democracy-seeking people

Features

Disadvantaged groups are more exposed to climate effects and less able to recover from damages. A Bangladeshi family travels to a safer location as water enters new areas after the cyclone Aila hit Bangladesh in 2009. Photo: Abir Abdullah

Climate and inequality entwinement imperils us all

18h | Panorama
A lesson on living the moment: 20 years of Kal Ho Naa Ho

A lesson on living the moment: 20 years of Kal Ho Naa Ho

1d | Features
In Barishal’s case, the low-cost of travel via waterways encourages people to migrate to Dhaka and other cities, like Chattogram. Photo: Syed Zakir Hossain

Why nearly a-fifth of people from Barishal moved to Dhaka

1d | Panorama
Photo: Salahuddin Ahmed/TBS

Political unrest hampers admission prep for HSC 2023 intake

1d | Education

More Videos from TBS

Why is Google deleting inactive accounts?

Why is Google deleting inactive accounts?

4h | Tech Talk
Ukraine is trying to increase exports amid fears

Ukraine is trying to increase exports amid fears

7h | TBS World
Cats and dogs in the whole house of one bigha of land in Narayanganj!

Cats and dogs in the whole house of one bigha of land in Narayanganj!

6h | TBS Stories
Referees being helped by British Airways pilots to improve VAR chaos

Referees being helped by British Airways pilots to improve VAR chaos

5h | TBS SPORTS
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]